scholarly journals Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents

MedChemComm ◽  
2018 ◽  
Vol 9 (7) ◽  
pp. 1131-1141 ◽  
Author(s):  
Junrong Song ◽  
Junjie Lan ◽  
Chao Chen ◽  
Shengcao Hu ◽  
Jialei Song ◽  
...  

Twenty-four 14-sulfonamide–tetrandrine derivatives were synthesized. Compound23exhibited growth inhibition of MDA-MB-231 cells with an IC50value of 1.18 ± 0.14 μM.

2021 ◽  
Vol 1226 ◽  
pp. 129351
Author(s):  
Reddymasu Sireesha ◽  
Reddymasu Sreenivasulu ◽  
Choragudi Chandrasekhar ◽  
Surender Singh Jadav ◽  
Y. Pavani ◽  
...  

2021 ◽  
Vol 36 (1) ◽  
pp. 1732-1750
Author(s):  
Mohammed M. Alanazi ◽  
Elwan Alaa ◽  
Nawaf A. Alsaif ◽  
Ahmad J. Obaidullah ◽  
Hamad M. Alkahtani ◽  
...  

INDIAN DRUGS ◽  
2019 ◽  
Vol 56 (03) ◽  
pp. 12-17
Author(s):  
Manpreet Kaur ◽  
S. Singh ◽  

A new series of 2,5-disubstituted-1,3,4-oxadiazole derivatives has been synthesized with the help of different aromatic benzaldehydes and final compounds were characterized by FTIR and 1H NMR. 2,5- disubstituted-1,3,4-oxadiazole derivatives were synthesized by the reaction of Schiff base derivatives with 2,5-disubstituted-1,3,4-oxadiazoles. All the synthesized compounds were screened for their anticancer activity. These compounds were evaluated for their anticancer activity against various cancer cell lines. Five of the compounds possessed good to moderate anti-cancer activity. Three of the synthesized compounds i.e. 6a, 6f and 6g were found to possess maximum growth inhibition. The order for the % control growth inhibition of MCF-7 was found to be 6a>6f>6g>5b>6h, as shown in Table II-VI.


2017 ◽  
Vol 2 (24) ◽  
pp. 7399-7406 ◽  
Author(s):  
Debojit Bhattacherjee ◽  
Chitra Basu ◽  
Queen Bhardwaj ◽  
Sourav Mal ◽  
Subhajit Sahu ◽  
...  

2019 ◽  
Vol 10 (34) ◽  
pp. 7946-7951 ◽  
Author(s):  
Hao Chen ◽  
Jing Wang ◽  
Xin Feng ◽  
Mark Zhu ◽  
Simon Hoffmann ◽  
...  

5BMF is a new fluorescent mitochondria-accumulating delocalized lipophilic cations [DLC] that boasts significantly increased anti-cancer effects and low toxicity in comparison to previous DLCs, addressing current hurdles in DLC clinical translation.


2019 ◽  
Vol 27 (14) ◽  
pp. 3070-3081 ◽  
Author(s):  
Guifang Han ◽  
Lihua Qing ◽  
Meng Wu ◽  
Yuxiang Wang ◽  
Yuxiu Liu ◽  
...  

2013 ◽  
Vol 23 (2) ◽  
pp. 642-659 ◽  
Author(s):  
A. Parthiban ◽  
J. Muthukumaran ◽  
A. Moushumi Priya ◽  
S. Jayachandran ◽  
R. Krishna ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document